YP
DGX icon

YANKCOM Partnership’s Quest Diagnostics DGX Stock Holding History

YANKCOM Partnership’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.46M Sell
6,258
-125
-2% -$28.9K 0.51% 42
2026
Q2 		$1.35M Buy
6,383
+184
+3% +$36.1K 0.49% 44
2026
Q1 		$1.21M Sell
6,199
-47
-0.8% -$9.13K 0.5% 50
2025
Q4 		$1.08M Buy
6,246
+20
+0.3% +$3.64K 0.46% 56
2025
Q3 		$1.19M Sell
6,226
-731
-11% -$130K 0.53% 49
2025
Q2 		$1.25M Buy
6,957
+14
+0.2% +$2.43K 0.61% 41
2025
Q1 		$1.17M Sell
6,943
-120
-2% -$19.7K 0.65% 41
2024
Q4 		$1.07M Buy
+7,063
New +$1.1M 0.57% 48

Other funds holding DGX

Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

YANKCOM Partnership's DGX Position: Q3 2026 in Review

YANKCOM Partnership reduced its Quest Diagnostics (DGX) stake by 2% in Q3 2026, selling an estimated $28.9K and leaving 6,258 shares worth $1.46M. The position accounts for 0.51% of the portfolio, ranked #42.

YANKCOM Partnership first reported a position in DGX in Q4 2024 and has held it in 8 quarters since. 722 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • YANKCOM Partnership held 6,258 shares of Quest Diagnostics worth $1.46M as of Q3 2026.
  • YANKCOM Partnership sold 125 Quest Diagnostics shares in Q3 2026, an estimated $28.9K.
  • Quest Diagnostics made up 0.51% of YANKCOM Partnership's portfolio in Q3 2026, its #42 holding.
  • YANKCOM Partnership first reported a position in Quest Diagnostics in Q4 2024 and has held it in 8 quarters since.
  • 722 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.